Blood RecoveryNCT05545930
Analysis of Red Blood Cell Integrity and Efficiency of Recovery Using a Novel Surgical Sponge-Blood Recovery Device (ProCell)
A study testing Hand Wrung and ProCell Wrung in people with Blood Recovery, run by University Hospitals Cleveland Medical Center at 1 site in United States.
Trial summary
The purpose of this research study is to compare two methods of recovering blood from surgical sponges used during heart and lung surgeries. The two methods are: 1) manually wringing sponges by hand, and 2) automated wringing sponges by an FDA approved suction device. Read more about this study
- Who is it for?
- Ages 18 to 89 years
- Conditions the study is for
- Blood Recovery
- What is being tested?
- Hand Wrung and ProCell Wrung
- Type of treatment
- Medical device, Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 1 siteUnited States
- Study dates
- 20 Sep 2022to 1 Feb 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 89 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Undergoing heart or lung transplant, redo sternotomy, aortic surgery, and/or multi-valve repairs/replacements; and
- At University Hospitals Cleveland Medical Center.
Who cannot join
- Patients with known bleeding disorders, including disseminated intravascular coagulation (DIC), prothrombin deficiency, factor V deficiency, factor VII deficiency, factor X deficiency, factor XI deficiency (hemophilia C), Glanzmann disease, hemophilia A, hemophilia B, idiopathic thrombocytopenic purpura (ITP), and Von Willebrand disease (types I, II, and III);
- Patients undergoing emergent or emergent salvage surgery; and
- Patients actively participating in another clinical trial which could affect outcomes.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
University Hospitals Cleveland Medical Center
Cleveland, Ohio, 44106
Craig Jarrett, MD, MBA, 216-286-7297, Craig.Jarrett@UHhospitals.org
About this study
The purpose of this research study is to compare two methods of recovering blood from surgical sponges used during heart and lung surgeries. The two methods are: 1) manually wringing sponges by hand, and 2) automated wringing sponges by an FDA approved suction device. Both methods are already in use in heart and lung surgeries at University Hospitals at the discretion of the surgeon.
- Conditions
- Blood Recovery
- Being tested
- Hand Wrung, ProCell Wrung
- Keywords
- Open Heart Surgery, Heart Transplant, Lung Transplant, ProCell
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Hand WrungProcedure or surgery
Hand wrung refers to manually wringing surgical sponges by hand.
ProCell WrungDevice
ProCell wrung refers to automated wringing surgical sponges by an FDA approved suction device (ProCell).
| Study group | Role | What they receive |
|---|---|---|
| Hand Wrung | Active comparator | Hand wrung refers to manually wringing surgical sponges by hand. Receives: Procedure: Hand Wrung |
| ProCell Wrung | Experimental | ProCell wrung refers to automated wringing surgical sponges by an FDA approved suction device (ProCell). Receives: Device: ProCell Wrung |
What is being measured
The primary outcome is the main question the study is designed to answer.
Level of Plasma Free Hemoglobin
Level of plasma free hemoglobin will be measured at baseline.
Measured: Baseline
Level of Plasma Free Hemoglobin
Level of plasma free hemoglobin will be measured post-processing.
Measured: Post-Processing (Up to 120 Minutes)
Change in Volume of Blood
Volume of blood will be measured at baseline and post-processing.
Measured: Baseline, Post-Processing (Up to 120 Minutes)
Secondary outcomes (8)
Number of Fragmented Red Blood Cells
Number of fragmented red blood cells will be measured at baseline.
Measured: Baseline
Number of Fragmented Red Blood Cells
Number of fragmented red blood cells will be measured post-processing.
Measured: Post-Processing (Up to 120 Minutes)
Level of Lactate Dehydrogenase
Level of lactate dehydrogenase will be measured at baseline.
Measured: Baseline
Level of Lactate Dehydrogenase
Level of lactate dehydrogenase will be measured post-processing.
Measured: Post-Processing (Up to 120 Minutes)
Level of Haptoglobin
Level of haptoglobin will be measured at baseline.
Measured: Baseline
Level of Haptoglobin
Level of haptoglobin will be measured post-processing.
Measured: Post-Processing (Up to 120 Minutes)
Change in Weight of Surgical Sponge
Weight of surgical sponges will be measured at baseline and post-procedure.
Measured: Baseline, Post-Procedure (Up to 5 Minutes)
Time to Wring Sponges
Time to wring sponges will be measured.
Measured: Up to 120 Minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Sep 2022
- Study start20 Sep 2022
- Primary completion1 Feb 2027 (estimated)
- Study completion1 Feb 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Blood RecoveryStudies of the same condition, open and under way.
- More trials run by University Hospitals Cleveland Medical CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Non-randomised
- Intervention model
- Crossover
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 20 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospitals Cleveland Medical Center
- Sponsor type
- University, hospital or other
- Collaborators
- ProCell Surgical Inc.
- Responsible party
- Principal investigator, Mohammad El Diasty, University Hospitals Cleveland Medical Center
- Investigators
- Rakesh Arora, MD, Principal investigator, University Hospitals Cleveland Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05545930
- Sponsor's protocol ID
- STUDY20220888
- Status last verified
- Sep 2026
- First submitted
- 14 Sep 2022
- Last updated
- 25 Sep 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Analysis of Red Blood Cell Integrity and Efficiency of Recovery Using a Novel Surgical Sponge-Blood Recovery Device (ProCell)
- ClinicalTrials.gov ID
- NCT05545930
- Acronym / sponsor ID
- STUDY20220888
- Conditions
- Blood Recovery
- Keywords
- Open Heart Surgery, Heart Transplant, Lung Transplant, ProCell
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 20 participants (estimated)
- Lead sponsor
- University Hospitals Cleveland Medical CenterUniversity, hospital or other
- Collaborators
- ProCell Surgical Inc.
- Study start
- 20 Sep 2022 (actual)
- Primary completion
- 1 Feb 2027 (estimated)
- Study completion
- 1 Feb 2027 (estimated)
- First posted
- 19 Sep 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this research study is to compare two methods of recovering blood from surgical sponges used during heart and lung surgeries. The two methods are: 1) manually wringing sponges by hand, and 2) automated wringing sponges by an FDA approved suction device. Both methods are already in use in heart and lung surgeries at University Hospitals at the discretion of the surgeon.
Study design
- Primary purpose
- Supportive care
- Allocation
- Non-randomised
- Intervention model
- Crossover
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Hand Wrung | Active comparator | Procedure: Hand WrungHand wrung refers to manually wringing surgical sponges by hand. |
| ProCell Wrung | Experimental | Device: ProCell WrungProCell wrung refers to automated wringing surgical sponges by an FDA approved suction device (ProCell). |
Who may qualify
- Ages
- 18 to 89 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Undergoing heart or lung transplant, redo sternotomy, aortic surgery, and/or multi-valve repairs/replacements; and
- At University Hospitals Cleveland Medical Center.
Key exclusion criteria (3 listed)
- Patients with known bleeding disorders, including disseminated intravascular coagulation (DIC), prothrombin deficiency, factor V deficiency, factor VII deficiency, factor X deficiency, factor XI deficiency (hemophilia C), Glanzmann disease, hemophilia A, hemophilia B, idiopathic thrombocytopenic purpura (ITP), and Von Willebrand disease (types I, II, and III);
- Patients undergoing emergent or emergent salvage surgery; and
- Patients actively participating in another clinical trial which could affect outcomes.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Hand WrungHand wrung refers to manually wringing surgical sponges by hand. | Procedure or surgery | Hand Wrung |
| ProCell WrungProCell wrung refers to automated wringing surgical sponges by an FDA approved suction device (ProCell). | Device | ProCell Wrung |
Primary outcome
Level of Plasma Free Hemoglobin
Time frame: Baseline
Level of plasma free hemoglobin will be measured at baseline.
Level of Plasma Free Hemoglobin
Time frame: Post-Processing (Up to 120 Minutes)
Level of plasma free hemoglobin will be measured post-processing.
Change in Volume of Blood
Time frame: Baseline, Post-Processing (Up to 120 Minutes)
Volume of blood will be measured at baseline and post-processing.
8 secondary outcomes
Number of Fragmented Red Blood Cells
Time frame: Baseline
Number of Fragmented Red Blood Cells
Time frame: Post-Processing (Up to 120 Minutes)
Level of Lactate Dehydrogenase
Time frame: Baseline
Level of Lactate Dehydrogenase
Time frame: Post-Processing (Up to 120 Minutes)
Level of Haptoglobin
Time frame: Baseline
Level of Haptoglobin
Time frame: Post-Processing (Up to 120 Minutes)
Change in Weight of Surgical Sponge
Time frame: Baseline, Post-Procedure (Up to 5 Minutes)
Time to Wring Sponges
Time frame: Up to 120 Minutes
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Sep 2026.
- Individual participant dataSharing planned: No
Related trials for Blood Recovery
Not yet recruitingObservational study
Systematic Intraoperative Cell Salvage in On-Pump Cardiac Surgery Within a Mature Patient Blood Management Programme
Cardiac Surgical Procedures, Blood Transfusion
Not yet recruiting
Virtual Reality Training Dose for Arm Recovery After Stroke: Clinical and Blood Biomarker Responses
Stroke, Upper Extremity Paresis
Enrolling by invitation
Recovery Modalities and Application Sequence in Elite Female Basketball Players
Basketball, Basketball Performance
RecruitingPhase 2
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
B-Cell Non-Hodgkin Lymphoma, Multiple Myeloma
Not yet recruiting
Exercise Intervention to Support Recovery After Allogeneic Stem Cell Transplantation in Adults With Myeloid Blood Disorders
Myeloid Malignancies
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Rakesh Arora, MD principal investigator
University Hospitals Cleveland Medical Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Hand Wrung and ProCell Wrung in people with Blood Recovery, run by University Hospitals Cleveland Medical Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 25 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Jessica Hungate, MD (216-844-3800, Jessica.Hungate@UHhospitals.org), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Level of Plasma Free Hemoglobin (time frame: Baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2026.